(Q42489280)

1 November 2017

title

Relationships between fibrinogen and insulin resistance (English)

1 reference

1 November 2017

1 reference

Raynaud E

1

1 reference

1 November 2017

Pérez-Martin A

2

1 reference

1 November 2017

Brun J

3

1 reference

1 November 2017

Aïssa-Benhaddad A

4

1 reference

1 November 2017

Fédou C

5

1 reference

1 November 2017

Mercier J

6

1 reference

1 November 2017

language of work or name

1 reference

1 June 2000

1 reference

1 November 2017

1 reference

1 November 2017

volume

150

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

365-370

1 reference

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Alteration of oxide reductive and haemostatic factors in type 2 diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Hemostasis variables in type I diabetic patients without demonstrable vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Relationship between hemorrheologic factors and insulin sensitivity in healthy young men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Association between fibrinogen levels and insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Influence of short-term submaximal exercise on parameters of glucose assimilation analyzed with the minimal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

The magnitude, the kinetics and the metabolic efficiency of first-phase insulin response to intravenous glucose are related

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Insulin resistance and cigarette smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Fatty acids, fibrinogen and blood flow: a general mechanism for hyperfibrinogenemia and its pathologic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

Fibrinogen, fibrinolysis and diabetes mellitus: a comment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

The expression of TNF alpha by human muscle. Relationship to insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900373-1

10.1016/S0021-9150(99)00373-1

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference